Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Regulatory News (HAYD)

Share Price Information for Haydale (HAYD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.375
Bid: 0.35
Ask: 0.40
Change: -0.015 (-3.85%)
Spread: 0.05 (14.286%)
Open: 0.385
High: 0.385
Low: 0.375
Prev. Close: 0.39
HAYD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

17 Oct 2016 07:00

RNS Number : 6338M
Haydale Graphene Industries PLC
17 October 2016
 

17 October 2016

Haydale Graphene Industries plc

("Haydale" or the "Company")

 

Grant of options

 

Haydale (AIM: HAYD), the Group focused on the commercialisation of graphene and other nano particle products using their proprietary plasma process announces that on 14 October 2016, the Board of the Company awarded options ("Options") over an aggregate of 78,254 ordinary shares of 2p each in the capital of the Company ("Ordinary Shares") pursuant to the Company's approved and unapproved share option schemes adopted by the Board on 4 April 2014. 

 

All of the Options granted have an exercise price of 198.14p per Ordinary Share (being the closing mid-market price of the Company's Ordinary Shares on 13 October 2016, the day before the grant) and will vest on the third anniversary of grant. On vesting, the Options will be exercisable until the tenth anniversary of grant. Following the grant of these Options, the Company's total number of options outstanding as at the date of this announcement is 1,149,890.

 

Of the Options granted, 25,044 were granted to directors of subsidiaries of the Company as follows:

 

Name

Number of unapproved options granted

Total number of options held

Total beneficial holding of Ordinary Shares

Shareholding %

Trevor Rudderham

19,411

19,411

10,000

0.06

Komkrit Sajjaanantakul

5,633

5,633

-

-

 

The grant of options to directors of subsidiaries, as outlined above, is a related party transaction for the purposes of Rule 13 of the AIM Rules for Companies. Accordingly, the directors of the Company, all of whom are independent of these transactions consider, having consulted with the Company's nominated adviser, Cairn Financial Partners LLP, that the option grants to Messrs Rudderham and Sajjaanantakul, as outlined above, are fair and reasonable insofar as Shareholders are concerned.

 

The number of ordinary shares currently in issue is 17,033,585 and it is this number that has been used to calculate the above percentage shareholdings.

 

For further information, please contact:

 

Haydale Graphene Industries plc

+44 (0) 1269 842 946

John Knowles, Chairman

Ray Gibbs, Chief Executive Officer

 

 

Cairn Financial Advisers LLP (Nomad)

+44 (0) 20 7213 0170

Tony Rawlinson

Emma Earl

 

 

Cantor Fitzgerald Europe (Broker)

+44 (0) 20 7894 7000

David Foreman (corporate finance)

David Banks (corporate broking)

Will Goode (corporate finance)

 

 

Hermes Financial PR

 

Trevor Phillips

Chris Steele

+44 (0) 7889 153 628

+44 (0) 7979 604 687

 

 

About Haydale

Haydale has developed a patented scalable plasma process to functionalise graphene and other nanomaterials. This enabling technology can provide Haydale with a rapid and highly cost-efficient method of supplying tailored solutions to enhance applications for both raw material suppliers and product manufacturers.

www.haydale.com Twitter: @haydalegraphene

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBUBDGSGBBGLU
Date   Source Headline
16th Jan 201711:45 amRNSDirector Dealing
23rd Dec 20167:00 amRNSIssue of Shares
15th Dec 20163:00 pmRNSResult of AGM
15th Dec 20167:00 amRNSAGM Statement
28th Nov 20167:00 amRNSAgreement with Huntsman Advanced Materials
22nd Nov 20167:00 amRNSAnnual Financial Report
19th Oct 20167:00 amRNSPDMR Dealings
18th Oct 20167:00 amRNSPDMR Dealings
17th Oct 20167:00 amRNSGrant of Options
13th Oct 20167:00 amRNSDistribution Agreement
13th Oct 20167:00 amRNSPDMR Dealings
11th Oct 20167:00 amRNSResult of Open Offer and Total Voting Rights
28th Sep 20167:00 amRNSContract Extension
23rd Sep 201610:57 amRNSResult of Placing
23rd Sep 20167:01 amRNSFinal Results
23rd Sep 20167:00 amRNSProposed Acquisition and Fundraise
9th Sep 20164:05 pmRNSCompletion of Innophene Acquisition
26th Aug 20167:00 amRNSDirector/PDMR Shareholding
25th Aug 20167:00 amRNSAcquisition and Issue of Equity
11th Aug 20167:00 amRNSGraphene Enhanced PLA Filaments for 3D Printing
8th Aug 20167:00 amRNSHaydale Funds New Professorial Chair Within WCPC
29th Jul 20167:00 amRNSBoard Change
7th Jun 201610:42 amRNSGrant of Warrants
26th May 20167:00 amRNSAgreement with Flowtite Technology AS
20th May 20163:27 pmRNSDirector Dealing
20th May 20167:00 amRNSGrant of Options
18th May 20167:00 amRNSReactor Supply and Collaboration Agreement
9th May 20167:00 amRNSInvestor Open Day
25th Apr 20164:40 pmRNSHolding(s) in Company
7th Apr 201611:28 amRNSCorrection: Joint Development & Supply Agreement
7th Apr 20167:00 amRNSJoint Development and Supply Agreement
22nd Mar 20167:00 amRNSHalf Yearly Report
14th Mar 20167:00 amRNSGraphene Enhanced Composite Products Launched
8th Mar 201611:12 amRNSNotice of Results
16th Feb 20167:00 amRNSGrant Awards
4th Feb 20167:00 amRNSHaydale Commission Composite Pipe Testing Facility
3rd Feb 20167:00 amRNSAcquisition of Rights and Grant of Warrants
3rd Dec 201511:58 amRNSResult of AGM
1st Dec 201512:05 pmRNSDirector Dealing
26th Nov 20157:00 amRNSHolding(s) in Company
25th Nov 20157:00 amRNSHolding(s) in Company
23rd Nov 201510:50 amRNSResults of General Meeting
20th Nov 20151:14 pmRNSResult of Open Offer
17th Nov 20157:00 amRNSGrant Awards
10th Nov 201511:32 amRNSNotice of AGM
6th Nov 20154:45 pmRNSPosting of Open Offer Application Forms
2nd Nov 201512:50 pmRNSDirector/PDMR Shareholding
2nd Nov 20157:01 amRNSIssue of Equity
2nd Nov 20157:00 amRNSFinal Results
14th Oct 20157:00 amRNSEuropean Patent Grant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.